Skip to content

GyneMD

Active
Private limited companyfounded 2024active for 1 yearBloemendal 19/A, 1700 Dilbeek, BelgiumKBO/BCE: BE 1017.077.167
Summary

GyneMD has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €69,584 and a net result of €66,584. The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Activity not known1 site
Size
€109,155total assets 2025
Equity
€69,584
Profit
€66,584
Turnover not published (micro format)
Financial health
86 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Accounts filed 52 days late0 of 1 deed read
Why 86raises riskLatest accounts 52 days late; 1 of the last 3 lateFounded in 2024lowers riskLiquidity: current ratio 2.37, cash €54,481Size: total assets €109,155Show the evidence

Checked score

Score 2025
86 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 73% of its sector peers (no NACE code, micro)
Financial strength
Strong
Solvency 89
equity 63.7% of total assets
Liquidity 85
short-term debt 33.5% · cash 49.9%
Profitability 100
return on assets 61.0%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 01-2026: 2.4% 02-2026: 2.5%▲ +0.1 percentage points vs 01-2026 03-2026: 2.5%● unchanged vs 02-2026 04-2026: 3.1%▲ +0.6 percentage points vs 03-2026 05-2026: 3.1%● unchanged vs 04-2026 06-2026: 3.4%▲ +0.3 percentage points vs 05-2026 07-2026: 3.6%▲ +0.2 percentage points vs 06-2026highest value 08-2026: 3.6%● unchanged vs 07-2026 09-2026: 3.5%▼ -0.1 percentage points vs 08-2026 10-2026: 0.4%▼ -3.1 percentage points vs 09-2026lowest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.37, above the usual 1.5; short-term debt: 33.5% and cash: 49.9% of total assets), and 36.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 53% on solvency, 77% on liquidity and 90% on profitability.

The bankruptcy probability was computed on 13-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.37, cash €54,481
NBB · annual accounts
lowers risk · Size: total assets €109,155
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Latest accounts 52 days late; 1 of the last 3 late
NBB · filings
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-09-2026, 52 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
52 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…

Financials · financial year 2025, micro format

2025 annual accounts filed late (52 days) Filed on 21 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00519102.

Equity
€69,584
Total assets
€109,155
Net result
€66,584
Working capital
€50,257

Turnover and EBIT margin not published: the micro format does not require them.

Balance-sheet composition
Assets €109,155
Fixed assets €22,327
Current assets €86,828
Equity and liabilities €109,155
Equity €69,584
Debt €39,571
Debt finances 36.3% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€106,970
Cash flow
€80,497
Current ratio
2.37
Debt to equity
0.57
ROE
95.7%
ROA
61.0%
Interest coverage
over 100
Debt ≤ 1 year
€36,571
Income taxes
€26,588

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 96.6% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
96.6% still going

For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,470 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 36 lines
Balance sheet Code2025
Assets
Total assets20/58€109,155
Fixed assets21/28€22,327
Tangible fixed assets22/27€22,327
Furniture and vehicles24€22,327
Current assets29/58€86,828
Amounts receivable within one year40/41€26,123
Trade receivables40€4,800
Other amounts receivable41€21,323
Cash at bank and in hand54/58€54,481
Deferred charges and accrued income490/1€6,224
Equity and liabilities
Total equity and liabilities10/49€109,155
Equity10/15€69,584
Contributions10/11€3,000
Reserves13€66,584
Distributable reserves133€66,584
Amounts payable17/49€39,571
Amounts payable within one year42/48€36,571
Trade debts44€218
Suppliers440/4€218
Taxes, remuneration and social security45€36,353
Taxes450/3€36,353
Accrued charges and deferred income492/3€3,000
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,913
Gross operating margin9900€106,970
Operating profit (loss)9901€93,058
Financial income75/76B€485
Recurring financial income75€485
Financial charges65/66B€371
Recurring financial charges65€371
Profit (loss) for the period before taxes9903€93,172
Income taxes67/77€26,588
Profit (loss) for the period9904€66,584
Profit (loss) for the period to be appropriated9905€66,584
Appropriation of the result
Profit (loss) to be appropriated9906€66,584
Transfer to equity691/2€66,584
To other reserves6921€66,584

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,913
Gross operating margin9900€106,970
Operating profit (loss)9901€93,058
Financial income75/76B€485
Recurring financial income75€485
Financial charges65/66B€371
Recurring financial charges65€371
Profit (loss) for the period before taxes9903€93,172
Income taxes67/77€26,588
Profit (loss) for the period9904€66,584
Profit (loss) for the period to be appropriated9905€66,584
Line2025
Assets
Total assets20/58€109,155
Fixed assets21/28€22,327
Tangible fixed assets22/27€22,327
Furniture and vehicles24€22,327
Current assets29/58€86,828
Amounts receivable within one year40/41€26,123
Trade receivables40€4,800
Other amounts receivable41€21,323
Cash at bank and in hand54/58€54,481
Deferred charges and accrued income490/1€6,224
Equity and liabilities
Total equity and liabilities10/49€109,155
Equity10/15€69,584
Contributions10/11€3,000
Reserves13€66,584
Distributable reserves133€66,584
Amounts payable17/49€39,571
Amounts payable within one year42/48€36,571
Trade debts44€218
Suppliers440/4€218
Taxes, remuneration and social security45€36,353
Taxes450/3€36,353
Accrued charges and deferred income492/3€3,000
Line2025
Profit (loss) for the period9904€66,584
+ Depreciation and write-downs630€13,913
Operating cash flow (approximation)€80,497

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (1)
Financial year Type Filed Reference
31-12-2025 micro format 21-09-2026 2026-00519102

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

GyneMD was incorporated on 6 December 2024 as a private limited company.1 The company has filed annual accounts once, for financial year 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2025

Acts, filings and financial milestones

2026
21-09
NBB filing Annual accounts filed
financial year 2025 · micro format · 52 days late
NBB filing
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded06-12-2024
Financial year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1017077167
Registered 19-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 14 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2024
registered office establishment The establishment unit on the map
Ground area
8,220 m²
Building footprint
1,341 m²
Parcel 23016B0256/00F005, Flanders. Linked by address, not a title deed.
1 establishment unit
GyneMD
Bloemendal 19/A, 1700 DilbeekSpecialist medical practice
since 2024unit no. 2.369.455.919
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
23016B0256/00F005 Flanders 8,220 m² 1 · 1,341 m² -
How the parcels are linked
Good to know
The parcel matches the address exactly.